These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32820665)

  • 21. Pharmacological prevention and treatment in clinical at-risk states for psychosis.
    Ruhrmann S; Klosterkötter J; Bodatsch M; Bechdolf A; Schimmelmann BG; Nikolaides A; Hilboll D; Schultze-Lutter F
    Curr Pharm Des; 2012; 18(4):550-7. PubMed ID: 22239587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depot antipsychotic drugs and prevention of psychotic relapse.
    Barnes TR
    Clin Neuropharmacol; 1991; 14 Suppl 2():S1-6. PubMed ID: 1684307
    [No Abstract]   [Full Text] [Related]  

  • 23. Rationale and parameters for medication-free research in psychosis.
    McGlashan TH
    Schizophr Bull; 2006 Apr; 32(2):300-2. PubMed ID: 16461574
    [No Abstract]   [Full Text] [Related]  

  • 24. Recovery from psychosis: physical health, antipsychotic medication and the daily dilemmas for mental health nurses.
    Bressington D; White J
    J Psychiatr Ment Health Nurs; 2015 Sep; 22(7):549-57. PubMed ID: 26234190
    [No Abstract]   [Full Text] [Related]  

  • 25. Should attenuated psychosis syndrome be included in DSM-5?
    Fusar-Poli P; Yung AR
    Lancet; 2012 Feb; 379(9816):591-2. PubMed ID: 22340290
    [No Abstract]   [Full Text] [Related]  

  • 26. Atypical neuroleptics, dose-response relationships, and treatment-resistant psychosis.
    Cohen BM; Benes FM; Baldessarini RJ
    Arch Gen Psychiatry; 1989 Apr; 46(4):381-3. PubMed ID: 2564764
    [No Abstract]   [Full Text] [Related]  

  • 27. "Awakenings" effect with risperidone.
    Stip E; Tourjman V; Lew V; Fabian J; Cormier H; Landry P; Lalonde P; Cournoyer J
    Am J Psychiatry; 1995 Dec; 152(12):1833. PubMed ID: 8526260
    [No Abstract]   [Full Text] [Related]  

  • 28. Introduction. Antipsychotic agents: clinical, economic, and legal considerations in the treatment of psychosis.
    Lehman AF
    J Clin Psychiatry; 1999; 60 Suppl 19():3-4. PubMed ID: 10507274
    [No Abstract]   [Full Text] [Related]  

  • 29. Psychiatric research. Putting the brakes on psychosis.
    Schmidt C
    Science; 2007 May; 316(5827):976-7. PubMed ID: 17510340
    [No Abstract]   [Full Text] [Related]  

  • 30. The sigma receptor: a novel site implicated in psychosis and antipsychotic drug efficacy.
    Deutsch SI; Weizman A; Goldman ME; Morihisa JM
    Clin Neuropharmacol; 1988 Apr; 11(2):105-19. PubMed ID: 2897876
    [No Abstract]   [Full Text] [Related]  

  • 31. Cannabidiol and Sodium Nitroprusside: Two Novel Neuromodulatory Pharmacological Interventions to Treat and Prevent Psychosis.
    Crippa JA; Hallak JE; Abílio VC; de Lacerda AL; Zuardi AW
    CNS Neurol Disord Drug Targets; 2015; 14(8):970-8. PubMed ID: 26350340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits of atypical antipsychotic medications in the treatment of psychosis.
    White DL
    Kans Nurse; 2003; 78(10):1-2. PubMed ID: 14746070
    [No Abstract]   [Full Text] [Related]  

  • 33. The neuropharmacology of psychosis.
    Tamminga CA; Davis JM
    Schizophr Bull; 2007 Jul; 33(4):937-46. PubMed ID: 17562697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of psychosis with prochlorperazine in the ICU setting.
    Servis M; Miller B
    Psychosomatics; 1997; 38(6):589-90. PubMed ID: 9518347
    [No Abstract]   [Full Text] [Related]  

  • 35. Travel advice for patients with psychotic disorders.
    Brennan E; Kulkarni J
    Aust N Z J Psychiatry; 2014 Jul; 48(7):687. PubMed ID: 24413809
    [No Abstract]   [Full Text] [Related]  

  • 36. Risperidone for the treatment of psychosis associated with neurosarcoidosis.
    Popli AP
    J Clin Psychopharmacol; 1997 Apr; 17(2):132-3. PubMed ID: 10950486
    [No Abstract]   [Full Text] [Related]  

  • 37. Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.
    Weller A; Gleeson J; Alvarez-Jimenez M; McGorry P; Nelson B; Allott K; Bendall S; Bartholomeusz C; Koval P; Harrigan S; O'Donoghue B; Fornito A; Pantelis C; Paul Amminger G; Ratheesh A; Polari A; Wood SJ; van der El K; Ellinghaus C; Gates J; O'Connell J; Mueller M; Wunderink L; Killackey E
    Early Interv Psychiatry; 2019 Dec; 13(6):1345-1356. PubMed ID: 30488637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis.
    Nieman DH; Rike WH; Becker HE; Dingemans PM; van Amelsvoort TA; de Haan L; van der Gaag M; Denys DA; Linszen DH
    Int Clin Psychopharmacol; 2009 Jul; 24(4):223-8. PubMed ID: 19521246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The art of prescribing: pharmacological management of psychosis in Alzheimer's disease: clinical challenges associated with second-generation antipsychotic medications.
    Antai-Otong D
    Perspect Psychiatr Care; 2008 Apr; 44(2):120-3. PubMed ID: 18366366
    [No Abstract]   [Full Text] [Related]  

  • 40. Quetiapine in postpartum psychosis.
    Gobbi G
    J Clin Psychopharmacol; 2014 Dec; 34(6):744-5. PubMed ID: 24943395
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.